000 01288 a2200313 4500
005 20250518084923.0
264 0 _c20210112
008 202101s 0 0 eng d
022 _a1744-7682
024 7 _a10.1080/14712598.2020.1729735
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChou, Cassie K
245 0 0 _aAssessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy.
_h[electronic resource]
260 _bExpert opinion on biological therapy
_c06 2020
300 _a653-664 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAdrenal Cortex Hormones
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aAntigens, CD19
_ximmunology
650 0 4 _aCytokine Release Syndrome
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xadverse effects
650 0 4 _aNeurotoxicity Syndromes
_xdrug therapy
650 0 4 _aRisk Factors
650 0 4 _aSeverity of Illness Index
700 1 _aTurtle, Cameron J
773 0 _tExpert opinion on biological therapy
_gvol. 20
_gno. 6
_gp. 653-664
856 4 0 _uhttps://doi.org/10.1080/14712598.2020.1729735
_zAvailable from publisher's website
999 _c30643831
_d30643831